Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Mid-range Performer

1010.0000 -6.40 (-0.63%)

NSE Jan 27, 2026 10:40 AM

101.54% Gain from 52W Low

Volume: 1.5M

Laurus Labs Ltd.

25 Apr 2025

1010.00

-0.63%

Laurus Labs (HOLD): Visibility of Operating Leverage

Hold: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Revenue/EBITDA/PAT exceeded our estimates by 8.4%/32.6%/110.3%; EBITDA margin surpassed our estimate by 440 bps

Laurus Labs has gained 67.59% in the last 1 Year